Gov. Kathy Hochul on Tuesday proposed the elimination of co-payments for insulin in New York, part of a wide-ranging consumer protection package unveiled ahead of her State of the State address next week.
More than 1.5 million New Yorkers have diabetes, according to the governor’s office. But the insulin many diabetics need to survive is the subject of extravagant price gouging in the United States by drugmakers; a month’s supply can cost hundreds of dollars, and even with insurance the drug is still typically much more expensive in the U.S. than in other countries.
